2026 SUFU Foundation Study of Neuromodulation Research Proposals RFA
Forecasted
The 2026 SUFU Foundation Study of Neuromodulation Research Proposals RFA funds research into innovative neuromodulation therapies for urinary, fecal, and pelvic pain disorders.
Funder: Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction
Due Dates (Anticipated): December 2026 (Full application deadline, projected)
Funding Amounts: Up to $25,000 per award; project duration up to 2 years
Summary: Supports research advancing innovative neuromodulation therapies for urinary, fecal, and pelvic pain disorders.
Key Information: PI or mentor must be a SUFU member; for trainees or junior faculty (≤5 years post-training).
Description
This grant, supported by the SUFU Foundation and Medtronic, is designed to advance research in neuromodulation for urinary, fecal, and pelvic pain disorders. The program encourages projects that explore efficacy, cost-effectiveness, mechanisms of action, and innovative methods of neuromodulation. Proposals should address significant barriers in the field, optimize therapeutic pathways, or develop novel approaches with the potential to transform clinical practice and scientific understanding in urology and pelvic medicine. All submissions undergo peer review for significance, innovation, approach, and research environment.
